Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: E_K_S who wrote (40422)	12/6/2010 4:22:52 PM
From: gcrispin	Read Replies (1) of 78741

I recently posted my thoughts on Merck as it is a stock I'm watching for an entry point due to tax selling. There are a number of things I like about it, principally the dividend. Message 27005714 I think it should be mentioned that Roche is also working on a CETP inhibitor. The results of the Phase III trial will be released before Merck trial is completed. roche.com Here are a couple of article that provide color to the question of efficacy for CETP inhibitors. healthcentral.com blogs.nejm.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next